{"title":"苯妥英致智力低下患者的体温过低","authors":"S. Soghoian, C. Heinis, M. Su","doi":"10.5580/14c3","DOIUrl":null,"url":null,"abstract":"Background: Phenytoin toxicity presenting as hypothermia has been reported in patients with mental retardation (MR), without causative explanation. We report a case in a patient with adrenal insufficiency. Case Report: A 50-year-old man with a history of MR and seizures was found lethargic. Medications included phenytoin and phenobarbital. Physical examination was unremarkable except for somnolence and hypothermia. The serum phenytoin level was 37 μg/mL (147 μmol/L). A cosyntropin stimulation test showed adrenal insufficiency. No infectious or inflammatory conditions were identified. The patient improved with supportive care, antibiotics and steroids. Discussion: The mechanism of phenytoin-associated hypothermia is unknown. It may be centrally mediated, or phenytoin may exert an indirect effect on hepatic steroid clearance leading to relative adrenal insufficiency. Conclusion: Significant hypothermia may occur with phenytoin toxicity. Clinicians should be alerted to this possibility and check a core temperature on patients at risk.","PeriodicalId":232166,"journal":{"name":"The Internet Journal of Neurology","volume":"105 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2007-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Phenytoin-induced Hypothermia in a Patient with Mental Retardation\",\"authors\":\"S. Soghoian, C. Heinis, M. Su\",\"doi\":\"10.5580/14c3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Phenytoin toxicity presenting as hypothermia has been reported in patients with mental retardation (MR), without causative explanation. We report a case in a patient with adrenal insufficiency. Case Report: A 50-year-old man with a history of MR and seizures was found lethargic. Medications included phenytoin and phenobarbital. Physical examination was unremarkable except for somnolence and hypothermia. The serum phenytoin level was 37 μg/mL (147 μmol/L). A cosyntropin stimulation test showed adrenal insufficiency. No infectious or inflammatory conditions were identified. The patient improved with supportive care, antibiotics and steroids. Discussion: The mechanism of phenytoin-associated hypothermia is unknown. It may be centrally mediated, or phenytoin may exert an indirect effect on hepatic steroid clearance leading to relative adrenal insufficiency. Conclusion: Significant hypothermia may occur with phenytoin toxicity. Clinicians should be alerted to this possibility and check a core temperature on patients at risk.\",\"PeriodicalId\":232166,\"journal\":{\"name\":\"The Internet Journal of Neurology\",\"volume\":\"105 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Internet Journal of Neurology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5580/14c3\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Internet Journal of Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5580/14c3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Phenytoin-induced Hypothermia in a Patient with Mental Retardation
Background: Phenytoin toxicity presenting as hypothermia has been reported in patients with mental retardation (MR), without causative explanation. We report a case in a patient with adrenal insufficiency. Case Report: A 50-year-old man with a history of MR and seizures was found lethargic. Medications included phenytoin and phenobarbital. Physical examination was unremarkable except for somnolence and hypothermia. The serum phenytoin level was 37 μg/mL (147 μmol/L). A cosyntropin stimulation test showed adrenal insufficiency. No infectious or inflammatory conditions were identified. The patient improved with supportive care, antibiotics and steroids. Discussion: The mechanism of phenytoin-associated hypothermia is unknown. It may be centrally mediated, or phenytoin may exert an indirect effect on hepatic steroid clearance leading to relative adrenal insufficiency. Conclusion: Significant hypothermia may occur with phenytoin toxicity. Clinicians should be alerted to this possibility and check a core temperature on patients at risk.